Complex Decongestive Physiotherapy Applied After Lymphovenous Anastomosis Surgery
Launched by NECMETTIN ERBAKAN UNIVERSITY · Dec 4, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called Complex Decongestive Physiotherapy (CDP) on patients with lymphedema, which is swelling that can occur after certain types of cancer treatment. The trial aims to compare two groups of patients: those who have had a specific surgery called lymphovenous anastomosis (LVA) and are receiving CDP, and those who have not had the surgery but are also receiving CDP. Researchers want to find out how effective these treatments are in reducing swelling and improving quality of life.
To participate in this study, individuals should be between 18 and 65 years old, have swelling in one arm or leg (not both), and have a specific type of lymphedema that has not been treated before. Participants should also have completed cancer treatments like surgery or radiation at least three months ago. Those who join the study can expect to receive personalized therapy and support, and their progress will be monitored throughout the trial. This is an important opportunity to help improve treatment options for lymphedema.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 18-65,
- • Having unilateral lower extremity or upper extremity lymphedema,
- • Being diagnosed with Stage 2 and 3 lymphedema,
- • Receiving lymphedema therapy for the first time,
- • Adjuvant chemotherapy for gynecological cancer,
- • Having completed radiation and surgical treatment at least 3 months and at most 5 years ago,
- • Patients with lymph vessels seen on lymphangiography,
- • Patients who have undergone LVA surgery and 1 month has passed since the surgery date
- • No evidence of disease recurrence at last follow-up visit and
- • Individuals willing to participate in the study
- Exclusion Criteria:
- • Those who do not volunteer to participate in the study,
- • Those with bilateral lower extremity lymphedema,
- • Having upper or lower extremity edema due to systemic disease,
- • Those with active infection,
- • Patients more than 1.5 months after LVA surgery
- • Known to have mental and cognitive disorders
- • Those who were unable to communicate and cooperate were not included.
About Necmettin Erbakan University
Necmettin Erbakan University is a prominent academic institution dedicated to advancing health sciences and research through innovative clinical trials. With a commitment to excellence in education and research, the university leverages its multidisciplinary approach to foster collaborations that enhance patient care and medical advancements. By conducting rigorous clinical studies, Necmettin Erbakan University seeks to contribute valuable insights to the medical community, ultimately improving treatment outcomes and fostering evidence-based practices in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, , Turkey
Konya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported